Elucidating the source of pathological FGF23 production in CSHS has important clinical consequences; nevi removal is both painful and associated with risk for patients, typically children, especially since evidence that it corrects hypophosphatemia is lacking. Here, FGF23 is linked to hypophosphatemia.